Drugs / Qinbudan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02313610 | Apr 2011 → Mar 2013 | pulmonary tuberculosis | Shanghai University of Traditional Chinese Medicine | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qinbudan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02313610 ↗ |
| Known as | QBDT | “Previously clinical studies have shown that the Qinbudan tablet (QBDT) promoted sputum-culture negative conversion and lesion absorption.” PMID 32381098 ↗ May 2020 |